Sprycel (dasatinib) — Medica
Gastrointestinal stromal tumor (GIST)
Initial criteria
- Patient is age ≥ 18 years.
- Patient has tried imatinib or Ayvakit (avapritinib tablets).
Reauthorization criteria
- Patient continues to meet initial criteria.
Approval duration
1 year